We are talking about vaccines, the development of which is at the final stage of clinical trials. The first stage to verify the safety of the drug was completed successfully, and the second stage was completed recently.
"Moderna biotechnology company was one of the first to announce the completion of a vaccine development supported by the Institute of Infectious Diseases of the USA. 45 American volunteers have already been vaccinated, and the drug’s safety test was successful," the report said.
It is not yet known in what volumes deliveries will be made.
The new vaccine is called mRNA-1273. It is based on transport RNA and, when introduced into the body, prevents the penetration of the virus into the cells. The vaccine suppresses the synthesis of the spiky protein of the virus, which is necessary for its attachment to cells. Thus, the vaccine prevents infection and allows the immune system to destroy the virus before it causes the disease.
As we reported before, the World Health Organization welcomed the initial results of clinical trials of dexamethasone, which, as scientists have found, reduces mortality from coronavirus by a third.